<DOC>
	<DOCNO>NCT00851175</DOCNO>
	<brief_summary>Rationale : Statins form class drug widely prescribe hypercholesterolaemia , specifically reduce risk atherosclerosis lower LDL-cholesterol . Next effect drug originally develop , become obvious statin several beneficial effect . Such pleiotropic effect include activation ecto-5'-nucleotidase increase endogenous adenosine production ( dephosphorylation adenosine monophosphate adenosine ) subsequently cause vasodilation . A recent study Meijer et al ( yet publish ) show rosuvastatin significantly augment vasodilation brief period ischemia ( post occlusive reactive hyperaemia ) . However , yet verify whether increase post occlusive reactive hyperaemia truly cause rise extracellular adenosine subsequent adenosine receptor stimulation . In study , mechanism rosuvastatin augments post occlusive reactive hyperaemia investigate block adenosine receptor caffeine , competitive A1 A2 adenosine receptor antagonist . Caffeine substance safely use normal concentration block adenosine receptor . Hypothesis : The augment effect rosuvastatin PORH cause increase extracellular adenosine formation effect diminish block adenosine receptor use caffeine . Objective : To study influence caffeine post occlusive reactive hyperaemia 7 day treatment rosuvastatin . Study design : Open label cross-over design Study population : Healthy volunteer , 18-50 year age Intervention : Eight volunteer receive 7 day treatment rosuvastatin 20 mg daily rosuvastatin treatment caffeine administrate intra-arterially . Main study parameters/endpoints : Forearm blood flow ( FBF ) measure indicator post occlusive reactive hyperaemia ( PORH ) .</brief_summary>
	<brief_title>Is Augmentation PORH Rosuvastatin Adenosine-receptor Mediated ?</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Age 1850 Written inform consent History cardiovascular disease Hypertension ( supine position : systole &gt; 140 mmHg , diastole &gt; 90 mmHg ) Diabetes Mellitus ( fast glucose &gt; 7.0 mmol/L random glucose &gt; 11.0 mmol/L ) Hyperlipidemia ( fast total cholesterol &gt; 5.5 mmol/L random cholesterol &gt; 6.5 mmol/L ) Alanine amino transferase &gt; 90 U/L Creatin kinase &gt; 440 U/L Raised rhabdomyolysis risk ( GFR &lt; 80 ml/min and/or overt clinical sign hypothyroidism and/or myopathy family history Alcohol abuse Concommitant chronic use medication Participation druginvestigation previous 60 day check VIP check</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>